Tier 3 · Filer Universe
Anixa Biosciences Inc
ANIX · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$3.20
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0000715446
Liquidity rank
#4712
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $210,000.00 | 2024-10-31 | 0001493152-25-001787 |
| Annual diluted EPS | -0.34 | 2025-10-31 | 0001493152-26-001845 |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | -0.07 | 2026-04-30 | 0001493152-26-028105 |
SEC EDGAR Frames batch generated 2026-08-10T23:34:18.937Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqDHR · Tier 1 peerABT · Tier 1 peerBMY · Tier 1 peerTMO · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames